Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Varicella vaccine].

E da S Carvalho1

  • 1Departmento de Pediatria da Escola Paulista Medicina.

Jornal De Pediatria
|May 1, 1995
PubMed
Summary
This summary is machine-generated.

The varicella vaccine, developed in 1974, is highly effective in children, including those immunocompromised. This review covers its development, administration, and safety for widespread use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Varicella complications: study of 117 patients admitted to the Emílio Ribas Hospital].

AMB : revista da Associacao Medica Brasileira·1990
Same author

[Persistence of colonization time in patients infected by Salmonella].

AMB : revista da Associacao Medica Brasileira·1990
Same author

[An epidemic caused by Salmonella typhimurium at a neonatal unit].

AMB : revista da Associacao Medica Brasileira·1988
Same journal

Acetaminophen versus Ibuprofen for the management of hemodynamically significant patent ductus arteriosus in very low birth weight infants: randomized trial.

Jornal de pediatria·2026
Same journal

Cross-cultural adaptation into Brazilian Portuguese of an international questionnaire for the assessment of cardiopulmonary resuscitation knowledge among adolescents.

Jornal de pediatria·2026
Same journal

Evaluation of ChatGPT's reliability in answering questions about short stature and growth failure.

Jornal de pediatria·2026
Same journal

Validity of the Khamis-Roche method, relative to bone age, in Portuguese children and adolescents from 11 to 15 years.

Jornal de pediatria·2026
Same journal

Urogenital congenital anomalies in children under 9 years: global disease burden analysis and projections, 1990-2021.

Jornal de pediatria·2026
Same journal

Intraventricular hemorrhage in preterm newborns: a multicenter study in four Brazilian hospitals.

Jornal de pediatria·2026
See all related articles

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Context:

  • The varicella vaccine, developed by Takahashi and colleagues in 1974, represents a significant advancement in infectious disease prevention.
  • Its efficacy and safety profile have been established through extensive research and clinical application.

Purpose:

  • To review the development, administration, and outcomes of the varicella vaccine.
  • To discuss its effectiveness in both healthy and immunocompromised children.
  • To outline indications, side effects, precautions, and contraindications for varicella vaccination.

Summary:

  • The varicella vaccine demonstrates high efficacy in healthy children (nearly 100% seroconversion) and good protective responses in immunocompromised children (82-90% seroconversion).
  • It is the first live attenuated virus vaccine suitable for immunocompromised patients.

Related Experiment Videos

  • Simultaneous administration with other vaccines is feasible, requiring separate injection sites.

    • Impact:

    • The varicella vaccine is licensed in several countries for high-risk individuals.
    • Ongoing studies explore its combination with other vaccines.
    • It holds potential for future inclusion in routine preventive immunization schedules.